Literature DB >> 24281121

Ninety-day survival of a calf implanted with a continuous-flow total artificial heart.

William E Cohn1, Jo Anna Winkler, Steven Parnis, Gil G Costas, Sarah Beathard, Jeff Conger, O H Frazier.   

Abstract

We evaluated the effects of steady state flow and perfusion on end-organ function in a long-term calf model. The animal received a continuous-flow total artificial heart (CFTAH) that we created from two axial-flow ventricular assist devices. Pump flow, blood pressure, and other pump parameters were monitored throughout the study, as were arterial blood gas and hematologic values, including neurohormone levels. Some hematologic values were mildly abnormal transiently after surgery but returned to acceptable levels within the first week. During the 90-day study, the calf showed no signs of hemolysis or thrombosis. Its mental function remained normal, as evidenced by the animal's interest in its surroundings and response to stimuli. End-organ and vasomotor function was not adversely affected by 90 days of steady state flow. This was the first study in which CFTAH support of an animal model was maintained for this duration.

Entities:  

Mesh:

Year:  2014        PMID: 24281121     DOI: 10.1097/MAT.0000000000000026

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  3 in total

1.  First report of 90-day support of 2 calves with a continuous-flow total artificial heart.

Authors:  Jamshid H Karimov; Nader Moazami; Mariko Kobayashi; Shiva Sale; Kimberly Such; Nicole Byram; Gengo Sunagawa; David Horvath; Shengqiang Gao; Barry Kuban; Leonard A R Golding; Kiyotaka Fukamachi
Journal:  J Thorac Cardiovasc Surg       Date:  2015-06-18       Impact factor: 5.209

2.  Bud Frazier's 1,000 th implantation of a ventricular assist device.

Authors:  Mark S Slaughter
Journal:  Tex Heart Inst J       Date:  2014-04-01

3.  New continuous-flow total artificial heart and vascular permeability.

Authors:  Jun Feng; William E Cohn; Steven M Parnis; Neel R Sodha; Richard T Clements; Nicholas Sellke; O Howard Frazier; Frank W Sellke
Journal:  J Surg Res       Date:  2015-06-18       Impact factor: 2.192

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.